HIV Management in Russia vs. USA
HIV/AIDS remains a key public health concern in Russia.
Although government funding for ARV treatment and HIV research has increased in the last 10 years, the system is still under-funded and offers basic treatment options in comparison to the U.S. Discriminatory attitudes also create a barrier, leading to low treatment rates and poor management of the disease.
In this White Paper, our Global Antiviral team has used both primary and secondary research to compare the infrastructure of the healthcare systems in Russia and the U.S., seeking to understand the differences in the epidemic and how this influences the treatment management of patients.
![[WEBINAR] Dealmaking 2026: What’s Changing, What’s Not, and How to Position for the Next Wave](/sites/default/files/styles/list_item_image/public/ct/event/2026-03/deal.png?itok=NtU1lGCc)
